Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in histone demethylase KDM4 as cancer therapeutic targets
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, et al.
The FASEB Journal (2020) Vol. 34, Iss. 3, pp. 3461-3484
Open Access | Times Cited: 112

Showing 26-50 of 112 citing articles:

Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
Yanfang Yang, Ke Feng, Liying Yuan, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 1036-1052
Open Access | Times Cited: 19
Natural products modulating epigenetic mechanisms by affecting histone methylation/demethylation: Targeting cancer cells
Dawid Dorna, Adriana Grabowska, Jarosław Paluszczak
British Journal of Pharmacology (2023)
Closed Access | Times Cited: 12
The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities
Guan–Jun Yang, Changyun Li, Tao Fan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 645-663
Open Access | Times Cited: 11
FBXO22 promotes HCC angiogenesis and metastasis via RPS5/AKT/HIF-1α/VEGF-A signaling axis
Zhen Lei, Yiming Luo, Junli Lu, et al.
Cancer Gene Therapy (2025)
Open Access
Discovery of a first-in-class PROTAC degrader of histone lysine demethylase KDM4
Danni Rao, Yiting Wang, Xiaolong Yang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117410-117410
Closed Access
The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics
Hong‐Yi Lin, Ah‐Jung Jeon, Kaina Chen, et al.
British Journal of Cancer (2025)
Open Access
KDM4C works in concert with GATA1 to regulate heme metabolism in head and neck squamous cell carcinoma
Meng-Chen Wu, Shanmin Yang, Wei-Kai Fang, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase
Thomas P. Corner, Anthony Tumber, E. Salah, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Human 2-oxoglutarate-dependent oxygenases: nutrient sensors, stress responders, and disease mediators
Sally C. Fletcher, Mathew L. Coleman
Biochemical Society Transactions (2020) Vol. 48, Iss. 5, pp. 1843-1858
Open Access | Times Cited: 29
Enhanced Properties of a Benzimidazole Benzylpyrazole Lysine Demethylase Inhibitor: Mechanism-of-Action, Binding Site Analysis, and Activity in Cellular Models of Prostate Cancer
David M. Carter, Edgar Specker, P.H. Malecki, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 14266-14282
Open Access | Times Cited: 27
Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies
Yi Wang, Qiang Xie, Huidan Tan, et al.
Pharmacological Research (2021) Vol. 173, pp. 105702-105702
Closed Access | Times Cited: 26
Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells
So Young Kim, Supyong Hwang, Bora Lee, et al.
Chemico-Biological Interactions (2022) Vol. 353, pp. 109806-109806
Closed Access | Times Cited: 17
KDM4C promotes mouse hippocampal neural stem cell proliferation through modulating ApoE expression
Kun Zhu, Hanyue Zhang, Yan Luan, et al.
The FASEB Journal (2024) Vol. 38, Iss. 5
Closed Access | Times Cited: 3
Controllers of histone methylation-modifying enzymes in gastrointestinal cancers
Ling Li, Qing Song, Jing Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116488-116488
Open Access | Times Cited: 3
RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A
Dongbo Chen, Xingwang Xie, Yangjing Zhao, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 25
Mechanistic insights into KDM4A driven genomic instability
Nicolas L. Young, Ruhee Dere
Biochemical Society Transactions (2021) Vol. 49, Iss. 1, pp. 93-105
Open Access | Times Cited: 22
The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
Dawid Dorna, Jarosław Paluszczak
Cells (2022) Vol. 11, Iss. 6, pp. 1023-1023
Open Access | Times Cited: 15
The catalytic domains of all human KDM5 JmjC demethylases catalyse N‐methyl arginine demethylation
Joanna Bonnici, Razanne Oueini, E. Salah, et al.
FEBS Letters (2023) Vol. 597, Iss. 7, pp. 933-946
Open Access | Times Cited: 8
Pan‐Cancer Single‐Nucleus Total RNA Sequencing Using snHH‐Seq
Haide Chen, Xiunan Fang, Jikai Shao, et al.
Advanced Science (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 8
Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells
Felipe Arroyave, Diana Montaño, Fernando Lizcano
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8685-8685
Open Access | Times Cited: 23
RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway
Shanshan Sun, Fujun Yang, Yongcun Zhu, et al.
Life Sciences (2020) Vol. 262, pp. 118508-118508
Closed Access | Times Cited: 21
8-Hydroxyquinoline-modified ruthenium(ii) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy
Xiu-Rong Ma, Junjian Lu, Peixin Yang, et al.
Dalton Transactions (2022) Vol. 51, Iss. 36, pp. 13902-13909
Closed Access | Times Cited: 13
How Protein Methylation Regulates Steroid Receptor Function
Lucie Malbeteau, Ha Thuy Pham, Louisane Eve, et al.
Endocrine Reviews (2021) Vol. 43, Iss. 1, pp. 160-197
Open Access | Times Cited: 17
From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD)
Miguel de Menezes Vaidergorn, Flávio da Silva Emery, A. Ganesan
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 13980-14010
Closed Access | Times Cited: 16
Histone Demethylase JMJD2D: A Novel Player in Colorectal and Hepatocellular Cancers
Qiang Chen, Kesong Peng, Pingli Mo, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2841-2841
Open Access | Times Cited: 11

Scroll to top